Cannvas MedTech (CSE:MTEC) is a cannabis penny stocks company that sees a vital need for education in the cannabis sector.
Educating yourself about cannabis is important whether you use the drug yourself or not. Canada is about to become the first G7 country to legalize it and with that, the stigma surrounding marijuana will likely begin to lift, so it is important to know as much as possible about something that will become normalized into everyday life.
But let’s look a little closer at education in marijuana—what is this penny stocks company doing?
Cannabis Penny Stocks: Who is Cannvas MedTech?
Put simply, the Vancouver-Toronto based company wants to educate the world about the complexities of cannabis. It is doing so via its state-of-the-art website called Cannvas.me, which is a verified database detailing all-things marijuana related.
It is on this website that casual users, medical users, and anyone else in between can receive purely unbiased education about marijuana.
>> Car-sharing Service Getaround Raises $300 Million in Funding
Also, the site incorporates machine learning so it tailors to your recognized needs the more you use it.
Importantly, any medical information hosted by the site is verified by the company’s board of doctors, ensuring its legitimacy and also that the information isn’t skewed or biased.
Company CEO Shawn Moniz stated on the company: “We didn’t create a business need, we saw a gap and we filled it.” His sentiment is that, as it stands, information out there that hasn’t been sponsored by a company behind marijuana can be difficult to find. Impartial education is virtually unavailable.
Cannabis Penny Stocks: Cannvas MedTech
So if the company is filling a gap in the market, then all too soon it should impress investors by supplying a need. But it is early days; legalization hasn’t kicked in yet and when it does, that will be the time Cannvas MedTech should shine.
As it stands, Cannvas MedTech stocks are in the green but being a fairly new penny stocks company (it only launched in early July) there is much more room for this company to grow and its stock hasn’t done anything too major yet.
Featured Image: Cannvas MedTech
